IMAX (NYSE:IMAX) Posts Quarterly Earnings Results, Beats Estimates By $0.13 EPS

IMAX (NYSE:IMAXGet Free Report) posted its quarterly earnings data on Thursday. The company reported $0.43 EPS for the quarter, topping the consensus estimate of $0.30 by $0.13, FiscalAI reports. IMAX had a return on equity of 13.61% and a net margin of 9.08%.The firm had revenue of $102.84 million for the quarter, compared to the consensus estimate of $96.09 million. During the same quarter last year, the company earned $0.26 earnings per share. The business’s revenue for the quarter was up 12.2% compared to the same quarter last year.

Here are the key takeaways from IMAX’s conference call:

  • IMAX said Q2 results beat consensus across key metrics, with revenue up 12% to $103 million, adjusted EPS up 65% to $0.43, and adjusted EBITDA of $48 million at a 46.6% margin.
  • The Odyssey is driving extraordinary early box office performance, including a $52 million global opening, 75% domestic occupancy, and record weekday holds, which management says could make 2026 box office a record year for IMAX.
  • Management highlighted a strong content pipeline for the back half of 2026 and into 2027, led by Dune: Part Three, Spider-Man: Brand New Day, and several other Filmed for IMAX and IMAX 70mm titles that could extend momentum.
  • Exhibitor demand remains strong, with 38 system installations in Q2 and 36 system signings, while year-to-date signings reached 62, supporting continued global network expansion.
  • IMAX is also pushing newer growth initiatives such as merchandising and an in-vehicle entertainment partnership in China, which management views as untapped opportunities but still early-stage.

IMAX Price Performance

IMAX stock opened at $43.96 on Friday. The stock has a market cap of $2.42 billion, a P/E ratio of 67.63, a PEG ratio of 1.44 and a beta of 0.37. IMAX has a 1 year low of $24.20 and a 1 year high of $45.52. The firm’s 50 day moving average price is $39.80 and its 200-day moving average price is $38.00.

Key Stories Impacting IMAX

Here are the key news stories impacting IMAX this week:

Insider Activity at IMAX

In related news, CEO Richard L. Gelfond sold 8,943 shares of the company’s stock in a transaction on Monday, April 27th. The shares were sold at an average price of $37.33, for a total transaction of $333,842.19. Following the completion of the transaction, the chief executive officer owned 765,002 shares in the company, valued at approximately $28,557,524.66. This represents a 1.16% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 20.55% of the company’s stock.

Institutional Trading of IMAX

A number of institutional investors and hedge funds have recently bought and sold shares of IMAX. CIBC Private Wealth Group LLC bought a new position in shares of IMAX during the 3rd quarter valued at about $27,000. Quarry LP increased its holdings in shares of IMAX by 166.8% in the fourth quarter. Quarry LP now owns 875 shares of the company’s stock worth $32,000 after purchasing an additional 547 shares during the last quarter. Caitong International Asset Management Co. Ltd increased its holdings in shares of IMAX by 2,310.4% in the third quarter. Caitong International Asset Management Co. Ltd now owns 1,157 shares of the company’s stock worth $38,000 after purchasing an additional 1,109 shares during the last quarter. Aster Capital Management DIFC Ltd lifted its position in shares of IMAX by 863.0% in the fourth quarter. Aster Capital Management DIFC Ltd now owns 1,666 shares of the company’s stock worth $62,000 after buying an additional 1,493 shares in the last quarter. Finally, Kestra Advisory Services LLC purchased a new stake in shares of IMAX in the fourth quarter worth about $74,000. 93.51% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms recently issued reports on IMAX. Benchmark reissued a “buy” rating on shares of IMAX in a report on Monday, June 22nd. Seaport Research Partners reiterated a “buy” rating and issued a $50.00 price target on shares of IMAX in a research report on Wednesday, June 24th. Roth Capital reissued a “buy” rating and issued a $48.00 price objective on shares of IMAX in a research note on Thursday. Wedbush raised their price objective on shares of IMAX from $46.00 to $54.00 and gave the company an “outperform” rating in a research report on Friday. Finally, Weiss Ratings upgraded shares of IMAX from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, July 16th. Ten analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $48.90.

View Our Latest Stock Report on IMAX

About IMAX

(Get Free Report)

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.

Read More

Earnings History for IMAX (NYSE:IMAX)

Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.